IHC for p53 (1:1,000, clone DO-7, DAKO, Santa Clara, CA, USA) and PTEN (1:1,000, clone Y184, Abcam, Cambridge, UK) was performed on 3-μm-thick sections from the TMA block using a Ventana automated immunostainer (BenchMark XT, Ventana Medical Systems, Tucson, AZ, USA), in accordance with the manufacturer's instructions. IHC was interpreted by intensity (negative, weak, and strong) and area (%). The PTEN and p53 expression were classified into three categories: (1) strong staining in ≥10% of the tumor cells was considered as strong positive, (2) samples without any nuclear staining of tumor cells were interpreted as negative, and (3) samples exhibiting weak staining in any area or patchy strong staining in <10% of tumor cells were regarded as weakly positive [28 (link)].